Growing teratoma syndrome after chemotherapy for a mixed germ cell tumor of the ovary
β Scribed by Yoshio Itani; Motohiro Kawa; Shinji Toyoda; Keizoh Yamagami; Katsutada Hiraoka
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 824 KB
- Volume
- 28
- Category
- Article
- ISSN
- 1341-8076
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
A retroperitoneal enlarging mass was detected and resected in a 24βyearβold nulliparous woman after fertilityβpreserving surgery and adjuvant chemotherapy for a malignant germ cell tumor (MGCT) of the right ovary. This enlarging mass contained only a mature teratoma component. Alphaβfetoprotein, which was elevated to 21236.6βng/mL before the initial surgery, persisted within normal after the completion of adjuvant platinumβbased chemotherapy. The patient was diagnosed with growing teratoma syndrome. Growing teratoma syndrome originating from ovarian germ cell tumor is very rare. Only 15 cases have been reported. Surgical resection and histological confirmation of growing mass after MGCT treatment is essential before conducting salvage chemotherapy.
π SIMILAR VOLUMES
## BACKGROUND. The growing teratoma syndrome is a recognized complication of
We report the cytogenetic findings in a case of mixed germ cell-sex cord-stromal tumor of the ovary in a 5-month-old girl. Monosomy 22 was observed as the sole karyotypic abnormality. This result was confirmed by comparative genomic hybridization, which revealed no additional chromosomal imbalances.
BACKGROUND. After chemotherapy for a
Primary alpha-fetoprotein secreting ovarian tumors have been detected in pregnancy by markedly elevated midtrimester MSAFP accompanied by sonographically visualized adnexal masses. We present a recurrent mixed germ cell tumor manifesting only as a moderately elevated MSAFP screen. A 23-year-old para